| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 07/14/2011 | US20110172419 Process for the synthesis of cyclic carbamates |
| 07/14/2011 | US20110172245 Heterocyclic compound and use thereof |
| 07/14/2011 | US20110172223 Substituted Aryl Sulfone Derivatives as Calcium Channel Blockers |
| 07/14/2011 | US20110172174 Antibacterial agents |
| 07/14/2011 | CA2784647A1 Inhibitors of sphingosine kinase |
| 07/13/2011 | EP2343293A1 Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of t-cell proliferation and uses thereof |
| 07/13/2011 | EP2342179A1 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases |
| 07/13/2011 | EP2341777A1 Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions |
| 07/13/2011 | EP2341771A1 Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment |
| 07/13/2011 | EP1463502B1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
| 07/13/2011 | EP1432420B1 Benzimidazolidinone derivatives as muscarinic agents |
| 07/13/2011 | CN102124123A Novel nitroreductase enzymatic substrates |
| 07/13/2011 | CN102123994A N-carboxy amino acid anhydride and amino acid carbamate compound production method |
| 07/13/2011 | CN102123985A Fungicide N-cycloalkyl-N-biphenylmethyl-carboxamide derivatives |
| 07/13/2011 | CN101379047B Preparation of delmopinol |
| 07/13/2011 | CN101220002B Oxazolidinone compound as antimicrobial |
| 07/12/2011 | US7977387 Aminobenzophenone compounds |
| 07/12/2011 | US7977362 Alpha-(N-benzenesulfonamido)cycloalkyl derivatives |
| 07/12/2011 | US7977332 Insecticidal N-(heteroarylalkyl)alkanediamine derivatives |
| 07/12/2011 | US7977322 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders |
| 07/12/2011 | CA2389685C Novel heterocyclic compounds and their use as medicaments |
| 07/07/2011 | WO2011082077A1 Hepatitis c virus inhibitors |
| 07/07/2011 | US20110166359 Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol |
| 07/07/2011 | US20110166157 2-Substituted-3-Phenylpropionic Acid Derivatives and Their Use in the Treatment of Inflammatory Bowel Disease |
| 07/07/2011 | US20110166130 Novel potassium channel blockers and uses thereof |
| 07/07/2011 | US20110165101 Photo-labile pro-fragrance conjugates |
| 07/06/2011 | EP2341047A1 Cyclohexane derivative and pharmaceutical use thereof |
| 07/06/2011 | CN1867554B Piperazine with or-substituted phenyl group and their use as GLYT1 inhibitors |
| 07/06/2011 | CN1777577B Antibacterial agents |
| 07/06/2011 | CN102115456A Cyanine compound, composition containing same and application in cell detection thereof |
| 07/06/2011 | CN102115224A Method for pretreating production waste water of fenoxaprop pesticide |
| 07/06/2011 | CN102114433A Supported arsine catalyst as well as synthesizing method and application thereof in Wittig reaction |
| 07/05/2011 | US7973169 including cystic fibrosis transmembrane conductance regulator ("CFTR"), such as N-(4,5-Diphenyl-thiazol-2-yl)-benzamide, used for treating genetic disorders; respiratory system disorders |
| 07/05/2011 | US7973061 Anaplastic lymphoma kinase modulators and methods of use |
| 07/05/2011 | US7973037 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 07/05/2011 | CA2549062C Novel oxazolidinone derivatives |
| 06/30/2011 | WO2011077310A1 Process for the preparation of linezolid |
| 06/30/2011 | WO2011077252A2 Metaxalone cocrystals |
| 06/30/2011 | WO2011055289A3 Carboxy oxazole or thiazole compounds as dgat - 1 inhibitors useful for the treatment of obesity |
| 06/30/2011 | US20110160225 Compositions and methods of use for treating or preventing lipid related disorders |
| 06/30/2011 | CA2785620A1 Process for the preparation of linezolid |
| 06/29/2011 | EP1699784B1 Novel oxazolidinone derivatives |
| 06/29/2011 | EP1326834B1 2-substituted heterocyclic compounds |
| 06/29/2011 | CN102112453A Novel potassium channel blockers and uses thereof |
| 06/29/2011 | CN102112430A Process for synthesis of ezetimibe and intermediates useful therefor |
| 06/29/2011 | CN102108068A Polymer material and application thereof |
| 06/28/2011 | US7968707 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
| 06/28/2011 | US7968577 Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| 06/28/2011 | US7968576 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 06/28/2011 | US7968567 Compounds for the modulation of PPARγ activity |
| 06/23/2011 | WO2011075631A1 Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of dpp-1 |
| 06/23/2011 | US20110152332 Pesticidal Heterocyclic Compounds |
| 06/23/2011 | US20110152331 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 06/23/2011 | US20110152330 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 06/23/2011 | US20110152318 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same |
| 06/23/2011 | US20110152290 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| 06/23/2011 | US20110152287 Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of dpp-1 |
| 06/23/2011 | US20110152246 Novel inhibitors of hepatitis c virus replication |
| 06/22/2011 | EP2335702A1 Product containing at least one phosphatase Cdc25 inhibitor combined with at least one other anticancer agent |
| 06/22/2011 | EP2334643A1 Phenethylamide derivatives and their heterocyclic analogues |
| 06/22/2011 | EP2334378A2 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
| 06/21/2011 | US7964735 Insecticidal 3-acylaminobenzanilides |
| 06/21/2011 | US7964622 Indole acetic acid derivatives and their use as pharmaceutical agents |
| 06/21/2011 | CA2641379C Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| 06/21/2011 | CA2554437C Amide derivatives, process for preparation thereof and use thereof as insecticide |
| 06/16/2011 | WO2011070177A2 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators |
| 06/16/2011 | WO2011070030A1 Heterocyclic sulfonamide derivatives |
| 06/16/2011 | WO2010149308A3 Substituted benzoxa (thia) zoles |
| 06/16/2011 | US20110144333 4,5-dihydro-oxazol-2yl derivatives |
| 06/16/2011 | US20110144326 Method for manufacturing stereoselective preparation of 4-BMA using a chiral auxiliary and chiral auxiliary |
| 06/16/2011 | US20110144168 Oxazolidine derivatives as nmda antagonists |
| 06/16/2011 | US20110144160 Antagonists of Prostaglandin D2 Receptors |
| 06/16/2011 | US20110144123 Thiazoles and Oxazoles Useful as Modulators of ATP-Binding Cassette Transporters |
| 06/16/2011 | US20110144119 Oxazole derivatives useful as inhibitors of faah |
| 06/16/2011 | US20110144057 Antagonists of the vanilloid receptor subtype 1 (vr1) and use thereof |
| 06/16/2011 | CA2783934A1 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators |
| 06/16/2011 | CA2781218A1 Heterocyclic sulfonamide derivatives |
| 06/15/2011 | EP2332912A1 Heteroarylaminosulfonylphenylderivates for use as sodium or calcium channel blockers in the treatment of pain |
| 06/15/2011 | EP2331534A1 Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators |
| 06/15/2011 | CN102093305A Method for preparing fenoxaprop-p-ethyl |
| 06/15/2011 | CN102093304A Preparation method of 3-R-2-sulfo-4-oxazolidinone |
| 06/15/2011 | CN102093303A (2R, 4S)-4-phenyl-2-methyl-2-trifluoromethyl oxazoline and preparation method thereof |
| 06/15/2011 | CN102093285A Cyclic amide derivatives, and their production and use as antithrombotic agents |
| 06/15/2011 | CN101137660B Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
| 06/14/2011 | US7960558 Pharmaceutical intermediate for synthesizing ACE inhibitors and the use thereof |
| 06/14/2011 | US7960544 Useful indole compounds |
| 06/14/2011 | US7960420 Diazonamide analogs with improved solubility |
| 06/14/2011 | CA2480678C New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 06/14/2011 | CA2445322C Use of the abc expression promoting agent pioglitazone for the treatment of arteriosclerosis obliterans |
| 06/09/2011 | WO2011067538A1 Combretastatin derivative preparation method |
| 06/09/2011 | US20110136735 Cyclohexane derivatives and uses thereof |
| 06/09/2011 | CA2782701A1 Combretastatin derivative preparation method |
| 06/08/2011 | EP2328875A2 Targeted nitroxide agents |
| 06/08/2011 | CN1926097B Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 06/08/2011 | CN101514190B Method for preparing heterocyclic compounds of methyl mercapto under ionic liquid catalysis |
| 06/08/2011 | CN101177416B (2'S,3'R,4S)-3-[2'-(N-substituted aminomethyl)-3'-hydroxy butyryl]-4-substituted oxazolidin-2-ketone derivative and preparation method thereof |
| 06/07/2011 | US7956182 Process for preparing optically active alcohols |
| 06/07/2011 | US7956077 2-{-3,′2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl methoxy}-propionic acid derivatives used as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes |
| 06/07/2011 | US7956075 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain. |
| 06/07/2011 | US7956055 Substituted gamma lactams as therapeutic agents |